“….I was always asking myself, who profited in Shermans’ case..”
IMO, based on the known specific people that have been consistently and repeatedly discussed on these threads for 8 years, there are, IMO only 4 groups of people (a total of 10 people) who would have, could have, or THOUGHT they would or could, profit or benefit from the murders of BOTH BS and HS. A very small number of people. IMO, the fact that none of these 10 individuals have been cleared as suspects by LE is telling. MOO
Looking at it from another angle...
Only one out of four groups and very likely, 1/10 people is involved.
9 other people are living under a certain spell.
Is it possible that neither of these people is involved.
Haven't we seen it?
Delphi case should be ideal example.
Current case that US media is actively covering will likely end up with totally different culprits than initially discussed. Although no one is cleared yet.
I don't know whether Toronto police is: 1) not too active; 2) has certain barriers because it is a high-profile case; 3) very likely, is overwhelmed by daily crimes and, to be frankly, not too incentivized to work at this case because "Apotex stays, and life goes on" or 4) the case is a complex maze with too many connections to ever solve.
So perhaps, we are just a tiny group interested in this mysterious case.
But I just asked AI if Barry Sherman was more litigious than average businessman
Answer:
"Barry Sherman, founder of Apotex, was considered exceptionally litigious, with experts describing his firm as potentially the most litigious in Canada and possibly overall.
Apotex filed an estimated 1,200 cases against the government in Federal Court, often challenging regulations, patents, and competitors, which cost taxpayers millions in legal fees.
Key details regarding his litigious nature include:
Aggressive Tactics: Sherman, through Apotex, frequently utilized the legal system to challenge pharmaceutical patents and government regulations.
Personal Disputes: Beyond corporate litigation, he engaged in long-running personal battles, including a decade-long lawsuit with his cousins over a claimed stake in his company.
Industry Impact: His approach, which some critics labeled unethical, was seen as a primary driver for high generic drug prices in Canada.
Reputation: Critics described him as a tough, sometimes "deplorable" operator who used litigation to eliminate competition and protect his market position."
MOO: while 10 people are not cleared, at best, one might be guilty. Or no one, with Barry's 1200 lawsuits. Too many people to be angry with him.